Submitted by Anonymous (not verified) on 23 September 2024 - 12:40
Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Date of authorisation: 16/02/2012, Revision: 27, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Date of authorisation: 16/02/2012, Revision: 27, Status: Authorised